A carregar...
Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration
AIMS: To examine 12-month outcomes of eyes switching from intravitreal ranibizumab to aflibercept for neovascular age-related macular degeneration (nAMD). METHODS: Database observational study of eyes with nAMD tracked by the Fight Retinal Blindness outcome registry that received ranibizumab for at...
Na minha lista:
Publicado no: | Br J Ophthalmol |
---|---|
Main Authors: | , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
BMJ Publishing Group
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5256411/ https://ncbi.nlm.nih.gov/pubmed/26994110 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2015-308090 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|